Evaluation of a Pharmacist-Led COVID-19 Vaccination Program in a Hospital Setting.

IF 1 Q4 PHARMACOLOGY & PHARMACY Journal of pharmacy practice Pub Date : 2024-08-01 Epub Date: 2023-08-19 DOI:10.1177/08971900231189355
Laura L John, Sydney Armbrust, Irina V Haller, Colleen M Renier, Alexa Brown, Elizabeth Monson
{"title":"Evaluation of a Pharmacist-Led COVID-19 Vaccination Program in a Hospital Setting.","authors":"Laura L John, Sydney Armbrust, Irina V Haller, Colleen M Renier, Alexa Brown, Elizabeth Monson","doi":"10.1177/08971900231189355","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> A pharmacist-led COVID-19 vaccination screening and administration tool was implemented at a tertiary care hospital in the Upper Midwest, allowing pharmacists to determine if an inpatient is a candidate for the COVID-19 vaccination. The purpose of this observational study was to examine the feasibility of a pharmacist-led, COVID-19 vaccination administration workflow to the inpatient population in a tertiary care hospital. <b>Methods:</b> This observational study was conducted at an Upper-Midwest facility and includes a study population of adult patients admitted to the hospital between 10/1/2021 - 1/1/2022. The primary outcome of this study was the number of COVID-19 vaccinations administered. Secondary outcomes included the number of attending physician approvals, pharmacist time dedicated to the vaccination program, patient demographics, and patient acceptance of vaccination. Group differences were evaluated using odds ratios, 95% confidence intervals, Pearson's chi-square test, the Mann-Whitney U test, and multivariate logistic regression. <b>Results:</b> There were 715 patients eligible to receive COVID-19 vaccination. Of those, 23 (3.2%) patients received a COVID-19 vaccine while inpatient. After adjusting for sex at birth, age at admission, and length of hospital stay, compared to previously unvaccinated patients, those with their second dose due were 7.3 times more likely to have been given a vaccination (95% CI 1.3-42.1, <i>P</i> = 0.026), while patients with their booster due were 4 times more likely to have been given a vaccination (95% CI 1.3-12.3, <i>P</i> = 0.014). <b>Conclusions:</b> Although unvaccinated patients were successfully identified, only 23 were able to be vaccinated. Additional barriers need to be addressed to make this program successful.</p>","PeriodicalId":16818,"journal":{"name":"Journal of pharmacy practice","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacy practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/08971900231189355","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/19 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: A pharmacist-led COVID-19 vaccination screening and administration tool was implemented at a tertiary care hospital in the Upper Midwest, allowing pharmacists to determine if an inpatient is a candidate for the COVID-19 vaccination. The purpose of this observational study was to examine the feasibility of a pharmacist-led, COVID-19 vaccination administration workflow to the inpatient population in a tertiary care hospital. Methods: This observational study was conducted at an Upper-Midwest facility and includes a study population of adult patients admitted to the hospital between 10/1/2021 - 1/1/2022. The primary outcome of this study was the number of COVID-19 vaccinations administered. Secondary outcomes included the number of attending physician approvals, pharmacist time dedicated to the vaccination program, patient demographics, and patient acceptance of vaccination. Group differences were evaluated using odds ratios, 95% confidence intervals, Pearson's chi-square test, the Mann-Whitney U test, and multivariate logistic regression. Results: There were 715 patients eligible to receive COVID-19 vaccination. Of those, 23 (3.2%) patients received a COVID-19 vaccine while inpatient. After adjusting for sex at birth, age at admission, and length of hospital stay, compared to previously unvaccinated patients, those with their second dose due were 7.3 times more likely to have been given a vaccination (95% CI 1.3-42.1, P = 0.026), while patients with their booster due were 4 times more likely to have been given a vaccination (95% CI 1.3-12.3, P = 0.014). Conclusions: Although unvaccinated patients were successfully identified, only 23 were able to be vaccinated. Additional barriers need to be addressed to make this program successful.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在医院环境中对药剂师主导的 COVID-19 疫苗接种计划进行评估。
目的:美国上中西部的一家三级护理医院采用了由药剂师主导的 COVID-19 疫苗接种筛查和管理工具,药剂师可据此确定住院病人是否适合接种 COVID-19。本观察性研究的目的是检验药剂师主导的 COVID-19 疫苗接种管理工作流程在一家三级医院住院病人中的可行性。方法:本观察性研究在美国上中西部的一家医院进行,研究对象为 2021 年 1 月 10 日至 2022 年 1 月 1 日期间入院的成年患者。本研究的主要结果是接种 COVID-19 疫苗的次数。次要结果包括主治医生批准的数量、药剂师为疫苗接种计划投入的时间、患者人口统计学特征以及患者对疫苗接种的接受程度。使用几率比、95% 置信区间、皮尔森卡方检验、曼-惠特尼 U 检验和多变量逻辑回归评估组间差异。结果共有 715 名患者符合接种 COVID-19 疫苗的条件。其中,23 名(3.2%)患者在住院期间接种了 COVID-19 疫苗。在对出生时的性别、入院时的年龄和住院时间进行调整后,与之前未接种疫苗的患者相比,第二剂到期的患者接种疫苗的几率是前者的 7.3 倍(95% CI 1.3-42.1,P = 0.026),而加强剂到期的患者接种疫苗的几率是前者的 4 倍(95% CI 1.3-12.3,P = 0.014)。结论虽然成功识别了未接种疫苗的患者,但只有 23 人能够接种疫苗。要使该计划取得成功,还需要解决更多的障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of pharmacy practice
Journal of pharmacy practice PHARMACOLOGY & PHARMACY-
CiteScore
3.20
自引率
7.70%
发文量
184
期刊介绍: The Journal of Pharmacy Practice offers the practicing pharmacist topical, important, and useful information to support pharmacy practice and pharmaceutical care and expand the pharmacist"s professional horizons. The journal is presented in a single-topic, scholarly review format. Guest editors are selected for expertise in the subject area, who then recruit contributors from that practice or topic area.
期刊最新文献
Impact of Pharmacist Intervention on Inappropriate Continuations of Antipsychotics upon ICU Discharge. Risk Factors Associated With Acute Kidney Injury in Traumatic Brain Injury Patients Treated With Hypertonic Saline: A Retrospective Study. Prescription for Digital Evolution: Transformative Recommendations for Pharmacy Practice in the Digital Age. The Effect of a Single-Dose Aminoglycoside With a Beta-Lactam for the Treatment of Gram-Negative Bacteremia. Bupropion in Comorbid Post-Traumatic Stress Disorder and Methamphetamine Use Disorder.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1